Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
DEA temporarily places three kratom-derived substances (mitragynine pseudoindoxyl, MGM-15, MGM-16) in Schedule I, making them illegal to possess or distribute. This does not directly affect cosmetics under MoCRA unless products contain these substances.
Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Cosmetic and personal care businesses that may use or sell products containing kratom or kratom derivatives, including indie beauty brands, contract manufacturers, private-label makers, and importers/distributors. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately upon publication of the temporary order (effective date in the Federal Register notice).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Three specific substances are now classified as Schedule I controlled substances, making their manufacture, distribution, or possession illegal under federal law.
Who it affects
Cosmetic and personal care businesses that may use or sell products containing kratom or kratom derivatives, including indie beauty brands, contract manufacturers, private-label makers, and importers/distributors.
What you must do
Review product formulations and ingredient sourcing to ensure none of these substances are present. If found, cease use and distribution immediately.
Deadline
Immediately upon publication of the temporary order (effective date in the Federal Register notice).
Never miss a change like this again
Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cosmetics & Personal-Care (MoCRA)
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Grants Seventh Approval under the National Priority Voucher Pilot Program
- FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics
- FDA Expands AI Capabilities and Completes Data Platform Consolidation
- FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection